Clinical trial

Effect of Valacyclovir in the Reduction of HSV-2 Recurrence and Shedding

NCT00803543

Study summary

ClinicalTrials.gov

Effect of Valacyclovir in the Reduction of HSV-2 Recurrence and Shedding

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Valacyclovir Normalized identity: valacyclovir View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-01-01

PhaseNA

Conditions

HIVunresolved

HIV Infectionsunresolved

Interventions

ValacyclovirDRUG · verified · RxNorm: valacyclovir

PlaceboDRUG

Sponsors & collaborators

University of Alabama at Birminghamlead sponsor

GlaxoSmithKlinecollaborator

Mapped research locations

BirminghamAlabama, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00803543 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.